Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04300257

Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

The primary significance of this project is to perform a detailed analysis to assess the diagnostics, treatment and follow-up care, to develop a prediction model for future patient selection regarding various diagnostic and treatment procedures.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Sarcoma Neoplasms Neoplasms by Histologic Type Neoplasms, Bone Tissue Neoplasms, Connective Tissue Neoplasms, Connective and Soft Tissue Osteosarcoma

Sex eligibility

All sexes

Study type

Observational

Primary location

Ente Ospedaliero Cantonale, Bellinzona, Canton Ticino, Switzerland

Loading trial locations.

About this study

Within the framework of interdisciplinary cooperation for a sarcoma problem, predictive and prognostic criteria will be developed that improve the treatment and particularly outcome.

The outcome variables include patient characteristics, tumor types and characteristics, histology, management and treatment strategies as well as recurrence rate and overall survival.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Malignant and intermediate and selected benign bone or soft tissue tumors, acc. to the WHO coding list of the SSN
  • Female and male subjects of all ages

Exclusion criteria

  • Documented objection of subsequent use of personal health data

Treatment and study plan

Primary outcomes

  1. Diagnosis,

    Time frame: 5 years

    Data collected in the registry will be evaluated and analyzed to determine criteria to improve treatment strategies

  2. Local recurrence,

    Time frame: 5 years

    s.o.

  3. distant metastasis,

    Time frame: 5 years

    s.o.

  4. biopsy taken by operating surgeon-radiologist-team,

    Time frame: 5 years

    s.o.

  5. pathology centrally reviewed,

    Time frame: 5 years

    s.o.

  6. Surgery (yes/no),

    Time frame: 5 years

    s.o.

  7. Surgical margin status,

    Time frame: 5 years

    s.o.

  8. surgery performed by dedicated surgeon,

    Time frame: 5 years

    s.o.

  9. Radiation Therapy (yes/no),

    Time frame: 5 years

    s.o.

  10. Chemotherapy (yes/no),

    Time frame: 5 years

    s.o.

  11. decision of board carried out,

    Time frame: 5 years

    s.o.

  12. Status at last contact,

    Time frame: 5 years

    s.o.

Study contacts

Contact information is provided by the study sponsor or research team.

Bruno Fuchs, Prof.

CONTACT

[email protected]

+41 52 266 25 33

Larissa Slater

CONTACT

[email protected]

+41 52 266 24 88

Sponsors and collaborators

Lead sponsor

Kantonsspital Winterthur KSW

Other

Collaborators

  • Swiss Sarcoma Network

Registry information

Important dates

Study start
2019
Primary completion
2029
Study completion
2029
First posted
Mar 9, 2020
Registry last updated
Mar 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.